Africa is ripe for increasing biomedical research and development; however, many African diaspora scientists have gone abroad for other opportunities. Many who do want to return face several major barriers in increasing their research links to the continent. To better understand these impediments, Egon Zehnder partnered with the UK Medical Research Council (MRC) to interview 15 African biomedical scientists from around the world to explore what is preventing African biomedical scientists based abroad from increasing their involvement with African research institutes and local African scientific talent and potential solutions to overcome these barriers.
Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at using virtual meetings, European Biotech leaders reveal to Egon Zehnder in a recent digital gathering.
On June 30, Egon Zehnder virtually gathered 15 top HR leaders from across biopharma, including European-based and U.S.-based companies, ranging from big pharma to start-up biotech. It was a lively discussion, with participants curious to learn from one another and generous in sharing their own insights, hopes, and concerns.
On April 8 and 9 Egon Zehnder virtually convened a number of biotech board directors to discuss some of the challenges being faced by their companies, often on the front line of responding to COVID-19.
On March 28, our global health care practice convened a virtual meeting with 15 CEOs around the world to discuss how to ensure financial strength, secure the supply chain, and the future of clinical trials.
You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.